Hepatocellular carcinoma (HCC) is one of the most common human malignancies in the world, ranking as the second leading cause of cancer-related death1. The high mortality is attributed to high rate of recurrence after hepatic resection (HR) and radiofrequency ablation (RFA)2, with a 5-year ...